T1	intervention 25 41	aerobic exercise
T2	control 629 636	control
T3	control-participants 660 662	41
T4	intervention-participants 715 717	38
T5	intervention-participants 774 776	37
T6	eligibility 526 594	premenopausal women who were at high risk of developing breast cance
T7	outcome-Measure 1050 1172	chemokine (C-C motif) ligand 2 (CCL2), interleukin 10 (IL-10), interleukin 12 (IL-12), and tumor necrosis factor α (TNF-α)
T8	outcome 1804 1842	IL-12 and TNF-α, the percentage change
T10	outcome 1926 1942	high-dose (IL-12
T9	outcome 1875 1890	low-dose (IL-12
T11	outcome 1231 1262	proinflammatory biomarkers CCL2
T12	outcome 1382 1387	IL-12
T13	outcome 1510 1515	TNF-α
T14	outcome 1649 1676	anti-inflammatory biomarker
